Breaking news – Pagina 80 – AMD

Breaking news

Maggio 6, 2024 dario.olivero

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

Butler J, Shah SJ, Petrie MC, et al.
Lancet. Pub. Online 27 Apr 2024.

Leggi

Maggio 7, 2024 dario.olivero

New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus

Van der Schueren B, Vrijlandt P, Thomson A, et al.
Diabetologia. Pub. online 4 May 2024.

Leggi

Maggio 6, 2024 dario.olivero

Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease

Natale P, Palmer SC, Navaneethan SD, et al.
Cochrane Database Syst Rev. Pub. Online 29 Apr 2024.

Leggi

Maggio 6, 2024 dario.olivero

Point-counterpoint: The need for Do-It-Yourself (DIY) Open Source (OS) AID systems in type 1 diabetes management

Forlenza GP, Tabatabai I, Lewis D
Diabetes Technol Ther. Pub. Online 26 Apr 2024.

Leggi

Maggio 6, 2024 dario.olivero

Initiating GLP-1 therapy in combination with freestyle libre provides greater benefit compared to GLP-1 therapy alone

Wright EE Jr, Roberts GJ, Chuang JS, et al.
Diabetes Technol Ther. Pub. Online 26 Apr 2024.

Leggi

Maggio 6, 2024 dario.olivero

Discordance between mean glucose and time in range in relation to HbA_1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Sterner Isaksson S, Imberg H, Hirsch IB, et al.
Diabetologia. Pub. Online 26 Apr 2024.

Leggi

Maggio 6, 2024 dario.olivero

Predicting hypoglycemia and hyperglycemia risk during and after activity for adolescents with type 1 diabetes

Bergford S, Riddell MC, Gal R, et al.
Diabetes Technol Ther. Pub. Online 26 Apr 2024.

Leggi

Maggio 6, 2024 dario.olivero

Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial

Benhalima K, Beunen K, Van Wilder N, et al.
Lancet Diabetes Endocrinol. Pub. Online 29 Apr 2024.

Leggi

Maggio 2, 2024 dario.olivero

Cross-sectional, case-control and longitudinal associations between exposure to glucagon-like peptide-1 receptor agonists and the dispensing of antidepressants

Almeida OP, Fong Z, Hill Almeida LM, et al.
Diabetes Obes Metab. Pub. Online 23 Apr 2024.

Leggi

Maggio 2, 2024 dario.olivero

Cardiorenal outcomes and mortality after sodium-glucose cotransporter-2 inhibitor initiation in type 2 diabetes patients with percutaneous coronary intervention history

Kim JH, Lyu YS, Kim B, et al.
Diabetes Obes Metab. Pub. Online 21 Apr 2024.

Leggi